Latest Content

Below you will find the latest content for Prometic Life Sciences including press releases, financial documents, video & webinar updates. Specific therapeutic information can be accessed using the menu above.

  • Prometic Corporate Presentation August 2019

    Prometic Corporate Presentation August 2019

    Read PDF
  • Prometic reports financial results for second quarter 2019

    Prometic reports financial results for second quarter 2019

    Prometic today announced financial results for its fiscal 2019 second quarter ended June 30th 2019.

    Read Article
  • Correction of previous press release: Prometic to report its second quarter financial results and hold conference call

    Correction of previous press release: Prometic to report its second quarter financial results and hold conference call

    Prometic’s conference call will be held at 8:30 a.m. (EDT), rather than 11:00 a.m. (EDT) on Tuesday, August 13th, 2019.

    Read Article
  • Prometic to report its second quarter financial results and hold conference call

    Prometic to report its second quarter financial results and hold conference call

    Prometic will report its financial results for the second quarter ended June 30th, 2019 on Monday August 12th, 2019 after market close.

    Read Article
  • Press Releases

    Read More
  • Annual Report 2018

    Annual Report 2018

    2018 was once again a year filled with strong scientific and clinical program development achievements for Prometic.

    Read PDF
  • Quarterly Report 2018 Q3

    Quarterly Report 2018 Q3

    Successful Type C meeting with FDA: agreement on proposed plan of action for RyplazimTM (plasminogen) manufacturing process along with Substantial reduction in R&D costs of up to $30 million.

    Read PDF
  • Quarterly Report Q2 2018

    Quarterly Report Q2 2018

    Advanced multiple initiatives aimed at extending cash runway, including ongoing partnering discussions related to both PBI-4050 and RyplazimTM (plasminogen).

    Read PDF
  • Financial Reports

    Read Now
  • Board of Directors Charter 2019

    Board of Directors Charter 2019

    Read PDF
  • Audit, Risk and Finance Committee Charter 2017

    Audit, Risk and Finance Committee Charter 2017

    The Committee is mainly responsible for the corporation's financial reporting process, process to identify & manage risks, internal & external audit process, communication systems & capital structure.

    Read PDF
  • Chairman Mandate 2018

    Chairman Mandate 2018

    The chairman of the Board of Directors of Prometic Life Sciences Inc. chairs the meetings of the Board and assures its good functioning and the good functioning of the committees of the Board.

    Read PDF
  • Virtual Tour of Prometic Life Science's Manufacturing Process6:14

    Virtual Tour of Prometic Life Science's Manufacturing Process

    You will discover how our industry leading technology is now being used to extract and purify therapeutic proteins from human plasma to provide for the development of best in class products.

    Watch Video
  • Plasminogen Replacement Therapy for Congenital Plasminogen Deficiency2:17

    Plasminogen Replacement Therapy for Congenital Plasminogen Deficiency

    At Prometic Life Sciences we are committed to addressing unmet medical needs in rare diseases such as Congenital Plasminogen Deficiency (PLGD).

    Watch Video
  • Corporate Governance

    Read More
  • Joe Parker, MD: PBI-4050 Demonstrates Promising Efficacy Results for IPF Treatment1:41

    Joe Parker, MD: PBI-4050 Demonstrates Promising Efficacy Results for IPF Treatment

    Prometic Life Science's senior director details the promising efficacy PBI-4050 alone or in combination with nintedanib demonstrated for treatment of IPF.

    Watch Video
  • PLI Share Price

    View Now
  • loading
    Loading More...